SCHEMBL4347142

SCHEMBL4347142

CC(C)OC(Cc1ccc(NC(=O)OCc2ccc(C(F)(F)F)cc2)cc1)C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
PPARA Q07869 10/20 0.51
PPARG P37231 9/20 0.51
PPARD Q03181 4/20 0.51
MGLL Q99685 1/20 0.49
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
CTSL P07711 1/20 0.45
CTSK P43235 1/20 0.45
FPR2 P25090 1/20 0.45
POLB P06746 1/20 0.43
TRPV1 Q8NER1 1/20 0.41
MME P08473 1/20 0.41
ACE P12821 1/20 0.41
CPA1 P15085 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4334181 1.00 MEN1 (0.52) MEN1KMT2ASMN1; SMN2L3MBTL1PPARA
SCHEMBL4328261 0.90 MGLL (0.53) MEN1KMT2ASMN1; SMN2L3MBTL1PPARA
SCHEMBL4327522 0.89 PPARA (0.47) MEN1KMT2ASMN1; SMN2L3MBTL1PPARA
SCHEMBL4334192 0.89 MGLL (0.60) PPARAPPARGPPARDMGLLCTSL
SCHEMBL4335537 0.88 KMT2A (0.58) MEN1KMT2ASMN1; SMN2L3MBTL1PPARA
SCHEMBL4348517 0.88 MGLL (0.53) MEN1KMT2ASMN1; SMN2PPARAPPARG
SCHEMBL4335124 0.87 PPARG (0.54) MEN1KMT2ASMN1; SMN2L3MBTL1PPARA
SCHEMBL4329694 0.87 MGLL (0.48) MEN1KMT2ASMN1; SMN2L3MBTL1PPARA
SCHEMBL4335678 0.87 PPARA (0.44) MEN1KMT2ASMN1; SMN2L3MBTL1PPARA
SCHEMBL4333343 0.87 PPARA (0.44) MEN1KMT2ASMN1; SMN2L3MBTL1PPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-20040102634-A1 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-05-27 US disclosed
EP-1380562-A1 CARBOXYLIC ACID DERIVATIVE AND SALT THEREOF Eisai Co., Ltd. (JP) 2004-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040102634-A1 Carboxylic acid derivative and salt thereof GPR119, IRS1, SLC5A1 MEN1 4091/4885KMT2A 2774/4885SMN1; SMN2 3054/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.